Bioxytran, Inc. ($BIXT) charts its unique path. With diseases like cancer and pulmonary fibrosis in their sights, they're ushering in a new era of medical breakthroughs. Their solid market cap, impressive trading range, and consistent trading volumes indicate a bright future on the OTC horizon.